Archive


Category: Frontotemporal dementia prevalence

  • Addressing The Scattered Harbingers of Frontotemporal Dementia

    The present Frontotemporal dementia market comprises of symptomatic medications since no therapy has been approved to help affected patients. However, pharma companies such as TauRx Therapeutics, Axon Neuroscience SE, Prevail Therapeutics, Avid Radiopharmaceuticals, and Alector are actively working to buildup the Frontotemporal dementia pipeline. One of the most diverse groups of neurodegenerative conditions, Frontotemporal dementia […]